IBX Ann: Imagion to complete the MagSense HER2 Phase 1 Study - 21st Jun 2023, 8:27am

annb0t

annb0t

Top 20
IBX Ann: Imagion to complete the MagSense HER2 Phase 1 Study
Price Sensitive: Y
Date: 21st Jun 2023, 8:27am

>>> Read announcement: Google: IBX Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
IBX Ann: Imagion presents ovarian cancer data at AACR conference - 9th Oct 2023, 9:37am
Replies
0
Views
111
annb0t
annb0t
annb0t
IBX Ann: Imagion Biosystems Investor Newsletter - 6th Oct 2023, 12:21pm
Replies
0
Views
106
annb0t
annb0t
annb0t
IBX Ann: Imagion Announces New CEO - 19th Jun 2023, 8:31am
Replies
0
Views
138
annb0t
annb0t
annb0t
IBX Ann: Imagion initiates leadership restructuring plan - 28th Apr 2023, 10:16am
Replies
0
Views
190
annb0t
annb0t
annb0t
IBX Ann: Imagion Biosystems April 2023 Investor Newsletter - 13th Apr 2023, 11:33am
Replies
0
Views
144
annb0t
annb0t
Top Bottom